Therapy Validation

In the department of therapy validation we focus on the development and validation of novel therapeutic approaches and diagnostic methods. We cover the following topics:

  • Identification and validation of new protein biomarkers for diagnostic and therapeutic applications
  • Development and production of specific monoclonal antibodies and assays for detect biomarkers
  • Development of human therapeutic monoclonal antibodies for the treatment of tumorigenic and autoimmune diseases
  • Planning and execution of preclinical efficacy and safety studies for new drug candidates, ATMPs and medical devices under GLP or GLP-analogous conditions
  • Small-scale GMP production of therapeutic monoclonal antibodies for preclinical animal studies and clinical trials (Phase I and II)
Therapy Validation
© Fraunhofer IZI

The Department of Therapy Validation participates in the Fraunhofer Cluster of Excellence for Immune-Mediated Diseases with the project "Therapeutic strategies for the treatment of chronic inflammatory bowel diseases".